Para comprender cmo funcionan los medicamentos con GLP-1, es til observar lo que hace esta hormona de forma natural dentro del organismo
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) commonly studied for its interaction with pituitary signaling pathways and endocrine communication systems
In 2018, FDA published guidance to 503A pharmacies on what will be considered unauthorized compounding of a product that is essentially a copy of an FDA-approved product, with an exception available when the prescriber documents on the prescription that the compounded drug product produces a significant difference for the identified individual patient. Under the 2018 guidance, FDA generally does not intend to question prescriber determinations that are documented in a prescription or notation. To date, patient-specific GLP-1 compounding activities have often included adding supplemental ingredients to combat side effects of the GLP-1 products or customizing doses, with a significant percentage of prescriptions for customization written by telehealth prescribers
Ratner RE, Maggs D, Nielsen LL, Stonehouse AH, Poon T, Zhang B, Bicsak TA, Brodows RG, Kim DD
Use only under medical supervision